Get the Stockscreener App
85.41
0.74%
0.685
Boston Scientific Corp stock is traded at $85.41, with a volume of 2.79M.
It is up +0.74% in the last 24 hours and up +0.96% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$84.72
Open:
$84.54
24h Volume:
2.79M
Relative Volume:
0.53
Market Cap:
$125.63B
Revenue:
$15.91B
Net Income/Loss:
$1.79B
P/E Ratio:
104.15
EPS:
0.82
Net Cash Flow:
$1.69B
1W Performance:
+0.93%
1M Performance:
+0.96%
6M Performance:
+17.16%
1Y Performance:
+62.48%
1-Day Range:
$84.13
$85.45
1-Week Range:
$80.64
$85.45
52-Week Range:
$50.84
$88.79
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific to Speak at Conference - Baystreet.ca
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference - StockTitan
Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition - Medical Device Network
Boston Sci to acquire Cortex, expand AF portfolio - BioWorld Online
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock - Investing.com
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock By Investing.com - Investing.com UK
TD Cowen maintains Buy rating on Boston Scientific with $100 target - Investing.com
Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI - GlobeNewswire Inc.
Are Wall Street Analysts Bullish On Boston Scientific Stock? - Barchart
Boston Scientific continues M&A run with Cortex buy - Yahoo Finance
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Earnings call: Boston Scientific focuses on cardiology growth and innovation - Investing.com India
Earnings call: Boston Scientific focuses on cardiology growth and innovation By Investing.com - Investing.com Canada
Boston Scientific (BSX): A Promising Medical Stock with Strong Revenue Growth - Insider Monkey
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX) - Yahoo Finance
Former Boston Scientific Exec Joins Transverse Medical’s Board - MPO-mag
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
The Zacks Analyst Blog The Progressive, Qualcomm, GE Aerospace, S&P Global and Boston Scientific - Zacks Investment Research
Boston Scientific Stock Gains From Market Expansion, Innovation - Yahoo Finance
J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree - MSN
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Looking for a Growth Stock? 3 Reasons Why Boston Scientific (BSX) is a Solid Choice - Yahoo Finance
The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction - Yahoo Finance
ACURATE study leaves Boston Scientific with lots of homework - BioWorld Online
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Dow Jones Composite Average (DOWC) QuotePress Release - The Globe and Mail
Up 45% YTD, Should You Buy This Outperforming Healthcare Stock? - MSN
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
TSX Composite Low Volatility (TXLV) QuotePress Release - The Globe and Mail
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific - Yahoo Finance
Why is Boston Scientific Stock Trading Lower On Wednesday? - Yahoo Finance
ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024 - Quantisnow
Boston Scientific TAVR trial misses non-inferiority mark - Investing.com
Boston Scientific Co. (NYSE:BSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vaginal Mesh Lawsuits in 2024 - Lawsuit Information Center Blog
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Corporation (NYSE:BSX) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? - Yahoo Finance
Boston Scientific Corp. stock rises Monday, still underperforms market - MarketWatch
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people - Yahoo Finance
Boston Scientific Halts Key Trial for FARAPULSE System Amid Unexpected Complications - Yahoo Finance
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end - MSN
Boston Scientific raises FY24 adjusted EPS view to $2.45-$2.47 from $2.38-$2.42 - MSN
Axonic’s stock soars after cash buyout deal with Boston Scientific valued at $3.7 billion - MSN
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Boston Scientific Raises Full-Year Guidance After Third-Quarter Beat - MSN
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Sci, Medtronic fare well in NICE review of remote monitoring - BioWorld Online
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):